Skip to main content
Fig. 3 | Acta Neuropathologica Communications

Fig. 3

From: Tau modulation through AAV9 therapy augments Akt/Erk survival signalling in glaucoma mitigating the retinal degenerative phenotype

Fig. 3

Tau overexpressing mice retinas shows exacerbated degenerative changes in the inner retina in high-IOP glaucoma condition. A Chronic elevation of IOP in C57BL/6 mice eyes was induced by intracameral microbead injections in control, AAV-GFP and AAV-mTau administered mice for 2 months. B Positive scotopic threshold response (pSTR) traces from control, glaucoma, glaucoma + AAV-GFP, and glaucoma + AAV-mTau overexpression mice retinas, as indicated and C their pSTR amplitudes quantification indicated a significant decline of the pSTR in the glaucoma AAV9-tau overexpression animals. (n = 10, ***P < 0.001 ****P < 0.0001) D Western blot analysis of Tau, pTauS199/202 and pTauS404 levels in control and glaucomatous retina. β-actin was used as a loading control E Fold change of Tau, pTauS199/202 and pTau.S404 showed a significant increase in retinas in high IOP conditions (***P < 0.001, n = 3 each group, t-test). F H and E staining of retinal sections of control, glaucoma, glaucoma + AAV9-GFP, and glaucoma + AAV9-mTau mice (representative images, arrows indicate the changes in cell densities, Scale bar, 50 μm). G Quantification of the cell density in GCL indicated a significant decrease in the number of cells in glaucoma and AAV-tau overexpressed retinas compared to the controls (n = 5, ****P < 0.0001, One-way ANOVA analysis with Tukey’s multiple comparison test)

Back to article page